This short course is designed for professionals with a basic understanding of health technology assessment (HTA) who seek to deepen their knowledge and skills in evaluating interventions for rare diseases. Participants will gain an appreciation of the unique challenges that rare diseases pose for HTA due to limited evidence, small patient populations, and high treatment costs. A case study from Europe will be shared. The session will close with a discussion on the methodological challenges of HTA in rare disease.